UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040794
Receipt number R000046555
Scientific Title The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903)
Date of disclosure of the study information 2020/07/01
Last modified on 2023/07/11 17:26:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903)

Acronym

PALEM trial

Scientific Title

The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903)

Scientific Title:Acronym

PALEM trial

Region

Japan


Condition

Condition

bone metastases

Classification by specialty

Medicine in general Hematology and clinical oncology Orthopedics
Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To verify the immediate efficacy and safety of palliative arterial embolization for painful bone metastases

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) pain relief at 72 hours after arterial embolization(TAE)
2) adverse events related to TAE 2 weeks after TAE

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Arterial embolization with a spherical embolic material is performed for painful bone metastases.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Diagnosed as painful bone metastases
2)Strongest pain site matches the bone metastasis site
3)No spinal cord compression in the bone metastasis site
4)The patient has pain described over 5 in Numerical Rating Scale.
5)Patient has received some form of analgesic medication for pain relief.
6)Radiation therapy (RT) has not been performed on the site of arterial embolization within 2 months.
7)The patuient has not been started new chemotherapy or
8)Originated cancer is not limited.
9)promising over 1 month alive after treatment
10)eGFR is over 30 ml/min/1.73m2
11)PT-INR is over 1.5 and Platelet count is over 50000/dl.
12)over 20 years old
13)Signed a consent form

Key exclusion criteria

1)Difficult to hold rest position
2)The patient could not describe pain by Numeric Rating Scale.
3)Preexisting disorders of being allergic to iodinated contrast material
4)Cannot stop anticoagulants and antithrombotic drugs.
5)Qualified ineligible patients being this clinical trial by responsible doctor

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Yasunori
Middle name
Last name Arai

Organization

National Cancer Center Hospital East

Division name

Department of Diagnostic Radiology

Zip code

277-8577

Address

6-5-1 Kashiwanoha, Kashiwa-shi, Chiba

TEL

04-7133-1111

Email

yarai1976@gmail.com


Public contact

Name of contact person

1st name Yasunori
Middle name
Last name Arai

Organization

National Cancer Center Hospital East

Division name

Department of Diagnostic Radiology

Zip code

277-8577

Address

6-5-1 Kashiwanoha, Kashiwa-shi, Chiba

TEL

04-7133-1111

Homepage URL


Email

yarai1976@gmail.com


Sponsor or person

Institute

Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Japan Supportive, Palliative and Psychosocial Oncology Group(J-SUPPORT)

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Hospital East

Address

6-5-1 Kashiwanoha, Kashiwa-shi, Chiba

Tel

04-7133-1111

Email

yarai1976@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学(愛知県)
愛知県がんセンター (愛知県)
岩手医科大学 放射線科 (岩手県)
がん研究会有明病院 (東京都)
国家公務員共済組合連合会斗南病院 (北海道)
国立がん研究センター中央病院 (東京都)
国立がん研究センター東病院 (千葉県)
静岡県立がんセンター (静岡県)
順天堂大学 (東京都)
聖マリアンナ医科大学 (神奈川県)
手稲渓仁会病院 (北海道)
奈良県立医科大学 (奈良県)
北海道大学病院 (北海道)
琉球大学医学部付属病院 (沖縄県)
・追加参加施設 2022/01 追加
大阪大学 (大阪府)
神戸大学 (兵庫県)
慶応大学病院 (東京都)
済生会福岡総合病院 (福岡県)
市立奈良病院 (奈良県)
函館五稜郭病院 (北海道)
兵庫医科大学病院 (兵庫県)
兵庫県立がんセンター (兵庫県)
福知山市民病院 (京都府)
北海道がんセンター (北海道)


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 06 Month 15 Day

Date of IRB

2020 Year 11 Month 28 Day

Anticipated trial start date

2021 Year 03 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 16 Day

Last modified on

2023 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046555


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name